Japanese and American reports of randomized trials: differences in the reporting of adverse effects
- 30 April 1996
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 17 (2), 99-110
- https://doi.org/10.1016/s0197-2456(96)80001-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- On Authorship and AcknowledgmentsNew England Journal of Medicine, 1991
- Publication bias in clinical researchThe Lancet, 1991
- Lovastatin and simvastatin prevention studiesThe American Journal of Cardiology, 1990
- Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemiaThe American Journal of Cardiology, 1990
- Simvastatin: The clinical profileAmerican Journal Of Medicine, 1989
- Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multicenter study group II)The American Journal of Cardiology, 1989
- Lipid Lowering Drugs in Atherosclerosis—the HMG-CoA Reductase InhibitorsClinical and Experimental Hypertension. Part A: Theory and Practice, 1989
- HMG CoA Reductase InhibitorsDrugs, 1988
- Statistical Problems in the Reporting of Clinical TrialsNew England Journal of Medicine, 1987
- Clinical Effects of Feprazone in the Treatment of OsteoarthritisRinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1979